Table 1.
A comparison of the old and new guidelines for the detection and treatment of hypertension (based on Ramsey et al13).
New guidelines | ||
---|---|---|
Group | Definition | Treatment |
N5 | SBP = >200 mmHg or DBP = >110 mmHg | Drugs |
N4 | SBP = 160–199 mmHg or DBP = 100–109 mmHg | Drugs |
N3(ii) | SBP = 140–159 mmHg or DBP = 90–99 mmHg; and clinical reason for screen or a high 10-year risk of CHD | Drugs |
N3(i) | SBP = 140–159 mmHg or DBP= 90–99 mmHg; and no clinical reason for screen and a low 10-year risk of CHD | Monitoring |
N2 | SBP = 135–139 mmHg or DBP = 85–89 mmHg | Monitoring (frequency depending on reading) |
N1 | SBP = <135 mmHg and DBP<85 mmHg | Reassessment in 5 years |
Old guidelines | ||
---|---|---|
Group | Definition | Treatment |
O4 | DBP = >100 mmHg | Drugs |
O3(i) | DBP = 90–99 mmHg; and clinical reason for screen or a higher 10-year risk of CHD | Drugs |
O3(ii) | DBP = 90–99 mmHg; and no clinical reason for screen and a low 10-year risk of CHD | Monitoring |
O2 | SBP = >160 and aged over 60 years | Drugs |
O1 | All other patients | No treatment |
SBP = systolic blood pressure; DBP = diastolic blood pressure; CHD = coronary heart disease.